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ABSTRACT
LncRNAs play crucial roles in cellular processes and their regulatory effects in the adult brain and neural stem
cells (NSCs) remain to be entirely characterized. We report that 10 lncRNAs (LincENC1, FABL, lincp21, HAUNT,
PERIL, lincBRN1a, lincBRN1b, HOTTIP, TUG1 and FENDRR) are expressed during murine NSCs differentiation
and interact with the RNA-binding protein ELAVL1/HuR. Furthermore, we characterize the function of two of
the deregulated lncRNAs, lincBRN1a and lincBRN1b, during NSCs’ differentiation. Their inhibition leads to the
induction of differentiation, with a concomitant decrease in stemness and an increase in neuronal markers,
indicating that they exert key functions in neuronal cells differentiation. Furthermore, we describe here that
HuR regulates their half-life, suggesting their synergic role in the differentiation process. We also identify six
human homologs (PANTR1, TUG1, HOTTIP, TP53COR, ELDRR and FENDRR) of the mentioned 10 lncRNAs and
we report their deregulation during human iPSCs differentiation into neurons. In conclusion, our results
strongly indicate a key synergic role for lncRNAs and HuR in neuronal stem cells fate.
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Introduction
Neural stem cells (NSCs) are multipotent stem cells present in
the central nervous system (CNS) with self-renewing capabilities
and the ability to generate all the main cellular phenotypes
present in the nervous system, including neurons, astrocytes
and oligodendrocytes [1]. NSCs were first observed as resident
progenitors in the sub-ventricular zone (SVZ) and dentate gyrus
of the mouse brain [2], and have later found a strong use in
regenerative medicine [3–9]. In that context, NSCs are described
to act both by releasing anti-inflammatory soluble factors and by
differentiating into cellular components of the CNS [4–12].
Many progresses have been made in understanding the factors
that regulate adult NSCs’ specification, proliferation and differ-
entiation, but much remains to be understood, especially the
potential involvement of RNA-binding proteins (RBPs) and long
non-coding RNAs (lncRNAs) in these processes [13].
LncRNAs are defined as RNA molecules longer than 200 bp
which can be classified as intergenic (lincRNAs), intronic, and cis-
antisense [14]. They have been endowed with a gene expression
regulatory ability, although their role is not limited to this func-
tion. Several well-studied examples of lncRNAs suggest that they
can operate through distinct modes, including working as signals,
scaffolds for protein–protein interactions, molecular decoys, and
guides to target elements in the genome or transcriptome [15].
The claim that lncRNAs could play a crucial role in development
was supported by the evidence that the ablation of specific
lincRNAs, such as PERIL and FENDRR, could cause perinatal
lethality in mouse knockout models [16]. Indeed, a fundamental
role in normal anatomical development has also been shown for
the lncRNA HOTTIP, which activates the expression of certain
Homebox A (HOXA) genes, crucial for distal identity and thus
correct limb development [17]. Moreover, a panel of lncRNAs
were found to be specifically expressed in the adult brain and/or
embryonic-stem derived NSC (ES-NSC), suggesting a potential
role for them in the development of the CNS. In particular,
lincBRN1a, lincBRN1b, FABL, FENDRR, HAUNT, lincp21 and
TUG1 were found to be expressed in ES-NSCs, implicating them
in the biology and cellular function of ES-NSCs [16].
Furthermore, two lncRNAs, lincBRN1a and lincBRN1b, have
been strongly correlated to neural development processes in mur-
ine knockout models [18]. This might be due to their potential
regulation of the neighbouring Pou3f3 locus, which has been
shown to have a role in coordinating neurogenesis and cortex
development [19]. Indeed, the two lncRNAs present specific
expression patterns in the adult brain. They have complementary
expression in the cerebral cortex, where lincBRN1a is strongly
expressed in layers II/III–IV and at lower levels in layers V–VI and
lincBRN1b is mainly expressed in layer V. Furthermore,
lincBRN1a and lincBRN1b have been shown to be expressed in
the hippocampus and in the medial habenular nucleus, respec-
tively [18].
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The roles that lncRNAs play at a cellular level are often
favoured by the interaction with partner proteins, which guide
their ability to activate or repress gene expression or to post-
transcriptionally regulate other RNAs [15]. Even so, very little is
known about their post-transcriptional and half-lives’ regulation
[20]. Indeed, the mechanism by which their own turnover is
regulated is still largely unexplored, and some evidences suggest
that a similar mechanism to the cis-trans, mRNA UTR-RNA-
binding protein (RBP) interaction could take place [20]. HuR/
ELAV1 (Human Antigen R; HuR) is a member of the RBP ELAV
(embryonic lethal abnormal version) family, well studied for its
role in RNA splicing and mRNA post-transcriptional regulation
[21–23]. HuR has recently been correlated to stem cells’ pluripo-
tency for its interaction with lncRNAs, such as linc-MD1, which is
involved inmuscle development [24]. HuR has also been reported
to influence lincp21’s decay in mouse fibroblasts, where this
interaction has been proposed to regulate the translation of
a subset of target mRNAs [25,26]. Furthermore, HuR is able to
influence the stemness state of mesenchymal stem cells by regu-
lating the mRNA turnover of the SOX2 master gene [27]. Less is
known about the regulatory pathways in which HuR and
lncRNAs are involved, and their molecular mechanisms of action,
particularly in neural precursor cells’ differentiation.
Here, we aimed to investigate the potential role of HuR’s
binding to specific lncRNAs during neural development. In parti-
cular, we focused on 11 lncRNAs (lincENC1, FABL, lincBRN1a,
lincBRN1b, lincp21, HOTTIP, HAUNT, TUG1, PERIL, FENDRR
and Mdgt) which have been selected for their role in murine
development [16]. We describe their interaction with the RBP
HuR, andwe investigate the role that HuR plays in regulating their
half-life duringNSCs differentiation.Moreover, we report that the
silencing of two of them (lincBRN1a and lincBRN1b) and the
inhibition of HuR’s activity (by siRNA or by using the specific
inhibitor dihydrotashinone) leads to the increase in differentiation
potential of NSCs, suggesting a role for the interaction in the
maintenance of the NSCs’ stemness state.
Materials and methods
Chemicals and antibodies
Di-hydrotashinone (DT, 1 µM, D0947, Sigma-Aldrich); actino-
mycin-D (1 μg/ml, CID 2019, Sigma-Aldrich); thiazolyl blue
tetrazolium bromide – MTT (M2128, Sigma-Aldrich); anti-
Nestin (MAB353, Millipore); anti-DCX (sc8066, Santa Cruz);
anti-HuR (390,600, Invitrogen); anti-βTubIII (MMS-435P,
Covance); anti-MAP2 (Ab5622, Millipore); anti-GFAP
(PRB571c, Covance); anti-GalC (Mab 342, Millipore); anti-
Olig2 (Ab9610, Millipore); pluripotent stem cells 4-Marker
Immunocytochemistry Kit (A24881, Thermo Fisher); 4,6, dia-
mino-2-phenyl-l-indole di-hydrocloride–DAPI (D259542,
Sigma-Aldrich), Alexa Fluor® 488 (Life Technologies) Alexa
Fluor® 546 (Life Technologies), cresyl-violet (Sigma-Aldrich),
Peroxidase AffiniPure Goat Anti-Rabbit/Mouse IgG (Jackson).
Primary cells isolation and differentiation
NSCs were obtained from 6-week-old CD-1 albino mice; their
isolation, growth and characterization were performed following
an already described protocol [28,29]. Briefly, cells were isolated
from the subventricular zone (SVZ) of adult male mice (CD-1)
immediately after their sacrifice by cervical dislocation. Brains
were removed and tissues containing the SVZ region were dis-
sected, transferred to Earl’s Balanced Salt Solution (Life
Technologies) containing 1 mg/ml papain (27 U/mg; Sigma-
Aldrich), 0.2 mg/ml cysteine (Sigma-Aldrich), and 0.2 mg/ml
EDTA (Sigma-Aldrich) and incubated for 45 min at 37°C on
a rocking platform. Tissues were then transferred in DMEM–
F12 medium (Euroclone), and mechanically dissociated with
a pasteur pipette. Cells were collected by centrifugation (200 _xg,
10 min, room temperature), and re-suspended in DMEM–F12
medium (Euroclone) containing 2 mm l-glutamine (Euroclone),
0.6% glucose (Sigma-Aldrich), 9.6 gm/ml putrescine (Sigma-
Aldrich), 6.3 ng/ml progesterone (Sigma-Aldrich), 5.2 ng/ml
sodium selenite (Sigma-Aldrich), 0.025 mg/ml insulin (Sigma-
Aldrich), 0.1 mg/ml transferrin (Sigma-Aldrich), and 2 μg/ml
heparin (sodium salt, grade II; Sigma-Aldrich), bFGF (human
recombinant, 10 ng/mL; Life Technologies) and EGF (human
recombinant, 20 ng/mL; Life Technologies). NSCs precursors
were maintained in culture in the previously mentioned medium.
Differentiation of NSCs was performed by plating the dissociated
stem cells at the density of 15,000 cells/cm2 in the presence of
adhesion molecules (Matrigel™, BD Biosciences), and bFGF
(10ng/ml) for 48 h, then cells were exposed to the same medium
without bFGF and with the addition of fetal bovine serum (2%
vol/vol; Euroclone) for the following 5 days as previously
described [29]. The extent of differentiation was then determined
by immunocytochemistry [29]. To inhibit HuR’s interaction with
target RNAs cells were treated with dihydrotashinone (DT) 1 μM
(Sigma-Aldrich D0947) [30].
Tissue collection and processing, histology and
immunohistochemistry
Animals were anaesthetized by intraperitoneal injection of 4%
cloralium hydrate (Sigma-Aldrich) in distilled water, and per-
fused with 4% paraformaldehyde (Sigma-Aldrich) in phosphate
buffer (PBS) (Life Technologies) 0.1 M pH 7.4 by trans-cardiac
perfusion. Brains were dissected and post-fixed overnight in the
same fixative, cryoprotected with 30% sucrose (Sigma-Aldrich),
quickly frozen, stored at −80°C, and sectioned by means of
a cryostat (CM 1850, Leica Microsystems). Sections (20 µm)
were rinsed with PBS, treated with blocking solution (Life
Technologies) and incubated with the appropriate primary anti-
body with antibodies against Nestin (monocl. 1:200; Millipore
MAB353); doublecortin (DCX, polycl. 1:500; Santa Cruz
sc8066); HuR (monocl. 1:250; Invitrogen 390,600); Glial
Fibrillary Acidic Protein (GFAP, polycl. 1:1000; Covance
PRB571c) overnight at 4°C. The sections were then washed
with PBS and incubated with appropriate secondary antibodies
(Alexa Fluor® 488 and 546, Life Technologies) for 2 hat room
temperature. Sections were then washed in PBS, nuclei were
stained with DAPI (1 µg/ml final concentration, 10 min at
room temperature), mounted using the FluorSave Reagent
(Calbiochem, Merck Chemical, Darmstadt, Germany), and ana-
lyzed by confocal microscopy (Confocal laser scanning micro-
scopy platform Leica TCS SP8, Leica Microsystems). In control
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determinations, primary antibody was omitted and replaced
with equivalent concentrations of unrelated IgG of the same
subclass. The ImageJ software was used for microphotographic
digital analysis. The positive pixels were quantified against the
negative background eliciting an index score which includes
fibres and neuronal bodies. The microscope light intensity of
the laser was the same for all analyzed sections and for determin-
ing the background optical density. For the quantification of
positive cells, the number of cells positive to the staining was
counted with respect to the total nuclei number. For cresyl violet
staining sections (20 µm) were rinsed thoroughly with PBS and
stained for 10 min with pre-heated cresyl-violet (Sigma-Aldrich)
. Sections were then left to cool down and subsequently
immersed in 95% ethanol for 5 min. Slides were then left to
dry and inserted in isopropanol for 3 min and then placed in
xylene for another 3 min and then covered with a coverslip.
Immunocytochemistry analysis
Cells were seeded on ethanol-washed glass coverslips, main-
tained in the appropriate culture medium, and then processed
for immunocytochemistry following already described proto-
col [29]. Briefly, cells were fixed with 4% paraformaldehyde in
PBS (Life Technologies) 0.1 M pH 7.4 for 10 min at room
temperature, and then washed with PBS. The coverslips were
incubated overnight at 4°C in PBS containing 10% normal
goat serum (NGS, Thermo Fisher), 0.3% Triton X-100 (BDH),
and the appropriate primary antibody. Cells characteristics
were assessed by immunocytochemistry with antibodies
against Nestin (monocl. 1:200; Millipore MAB353);
Doublecortin (DCX, polycl. 1:500; Santa Cruz sc8066); HuR
(monocl. 1:250; Invitrogen 390,600); βTubIII (monocl. 1:500;
Covance; MMS-435P); Microtubule-Associated Protein 2
(MAP2, polycl. 1:1000; Millipore Ab5622); Glial Fibrillary
Acidic Protein (GFAP, polycl. 1:1000; Covance PRB571c);
Galactocerebrosidase (GalC, monocl. 1:200; Millipore, Mab
342); Olig2 (polycl. 1:500; Millipore Ab9610). After thorough
washing with PBS and 10% NGS, cells were reacted for 45 min
(room temperature) with the appropriate secondary antibody
(Alexa Fluor® 488 and 546, Life Technologies). Nuclei were
stained with DAPI (1µg/ml final concentration, 10 min at
room temperature) mounted using the FluorSave Reagent
(Calbiochem, Merck Chemical, Darmstadt, Germany), and
analyzed by confocal microscopy (Confocal laser scanning
microscopy platform Leica TCS SP8, Leica Microsystems).
In control experiments, primary antibodies were omitted
and replaced with equivalent concentrations of unrelated
IgG of the same subclass. For the iPSCs characterization, the
Pluripotent Stem Cells 4-Marker Immunocytochemistry Kit
was used (Thermo Fisher A24881). The ImageJ software was
used for microphotographic digital analysis. The positive pix-
els were quantified against the negative background eliciting
an index score which includes fibres and neuronal bodies. The
microscope light intensity of the laser was the same for all
analyzed sections and for determining the background optical
density. For the quantification of positive cells, the number of
cells positive to the staining was counted with respect to the
total nuclei number.
Colorimetric assay for mammalian cells survival
MTT assay was performed as described by Slikker and collea-
gues [31]. Briefly, 15,000 cells/well were seeded in 48-wells
plate and differentiated or not, following the previously
described protocol [29]. Cells were treated or not with 1 μM
DT or silenced for HuR’s expression for 24 h before testing.
Ensight™ multimode plate reader (Perkin Elmer) was used to
measure absorbance at 560 nm.
RNA immunoprecipitation (RIP)
RIP was performed as reported in Latorre et al. 2016 [27] .
Briefly, cells were cultured in the different experimental con-
ditions (NSCs grown in floating conditions treated or not
with DT, and differentiated NSCs treated or not with DT)
and at the end of the treatments were syringed with a U-100
insulin needle in 500 µl lysis NT2 buffer (50 mM tris-HCl
pH7.7, 150 mM NaCl, 1 mM MgCl2; 0.05% NP40, 1 U/µl
RNase IN, 20 mM DTT, 1% BSA, Protease inhibitor cocktail)
chilled at 4°C. Lysate was centrifuged at 10,000 g for 10 min
then the supernatant was pre-cleared by interaction with
protein-A-coated agarose beads (equilibrated in NT2 buffer)
overnight at 4°C in constant shaking (100 µl slurry beads/500
µl lysate). 150 µl of the pre-cleared lysate was then incubated
with protein A-coated agarose beads anti-HuR antibody (or
control unrelated IgG) conjugated for 6 h at 4°C and then
washed twice in NT2 buffer. 20 µl protein A-coated slurry
agarose beads were conjugated with 4 µg antibody at room
temperature for 2 h, washed and equilibrated in NT2 lysis
buffer before use. RNA was isolated from the different sam-
ples (immunoprecipitated anti-HuR, unrelated IgG and pre-
cleared input) using TriZol Reagent (Invitrogen) following
standard protocol. The RNA quality was assessed using
a spectrophotometer (NANOPhotometer® NP80, IMPLEN)
and visualized on agarose gel. Total RNA (1 μg) was reverse
transcribed using iScript cDNA synthesis kit (Bio-Rad) fol-
lowing the manufacturer’s instructions and used as template
for Real-Time RT-PCR analysis [27]. Real-Time RT-PCR was
performed with StepOnePlusTM Real-Time PCR System
(Thermo Fisher) using iQ SYBR Green Supermix (Bio-Rad).
Genes were quantified in triplicates, and the results were
analyzed as fold enrichment relative to unrelated IgG, used
as IP negative control. Fold enrichment was calculated using
the 2−ΔΔCt method, with respect to unrelated IgG.
Real time-PCR
Total RNA from cultured cells and tissue samples was isolated
using TRIzol Reagent (Invitrogen) following standard protocol.
The RNA quality was assessed using a spectrophotometer
(NANOPhotometer® NP80, IMPLEN) and visualized on agarose
gel. Total RNA (1 μg) was reverse transcribed using iScript cDNA
synthesis kit (Bio-Rad) according to the manufacturer’s instruc-
tions. Using gene sequences available from NCBI for target genes
(www.ncbi.nlm.nih.gov/nucleotide) PCR oligonucleotide primers
for target genes were selected. This was done with the NCBI’s
Primer-BLAST tool (Supplementary Table 1). Real-Time PCR
was performed with StepOnePlusTM Real-Time RT-PCR System
RNA BIOLOGY 3
(Thermo Fisher) using iQ SYBR Green Supermix (Bio-Rad).
Genes were quantified in triplicates, m-GAPDH was used as
housekeeping gene for mouse samples and h-GAPDH was used
as housekeeping gene for human samples. Gene expression was
calculated using the 2−ΔΔCt method.
Gene silencing
Cells were silenced for HuR, lincBRN1a and lincBRN1b by
transient transfection with commercially available siRNA (HuR
MU00109-1 Sigma-Aldrich; lincBRN1a SIL. SEL. PRE-DSG.
SIRNAn516613 and n254090 Life Technologies; lincBRN1b
SIL. SEL. PRE-DSG. SIRNAn397945 and n397954 Life
Technologies). MISSION® siRNA Universal Negative Control
was used in Mock samples (SIC001). Transfection was per-
formed using Lipofectamine™ RNAiMAX (Invitrogen) following
the manufacturer’s instructions. Both in NSCs state and in dif-
ferentiation conditions the silencing lasted for 7 days and siRNA
molecules were added to the medium every 48 h.
Mutagenesis and luciferase activity
LncRNA sequences containing HuR-binding sites (lincBRN1a:
GAGGTATTTGAAAGGCAATCAGCCCGACCGTCCCCCT-
AGA; lincBRN1b: TATTAAAATAATAGTAATAAAAATA
AGAATAATAATTAAA) were synthesized as double-strand
DNA by Life Technologies manufacturer. They were then cloned
into a pMirTarget plasmid (Origene, Rockville, MD). Plasmid
3ʹUTR SOX2 was used as control [27]. The Pierce Firefly
Luciferase Flash Assay Kit (Sigma-Aldrich) was used according
to manufacturer’s instructions 24 h after transfection with
Lipofectamine™ 2000 (Invitrogen).
Western blot
Cell protein extracts were obtained by means of RIPA lysis buffer.
Equal amounts of solubilized proteins were heated in Laemmli
sample buffer (Bio-Rad) containing 2-βmercaptoethanol (70 mM,
Sigma), separated by SDS-PAGE gel 10% and electroblotted onto
a nitrocellulose membrane (GE Healthcare, Amersham™).
Membranes were then blocked in 5% slim milk (diluted in TBS
with 0.05% Tween-20) and probed with the appropriate primary
antibody against HuR (monocl. 1:200; Invitrogen 390,600); β-
actin (monocl 1:1000; Sigma-Aldrich A1978) overnight at 4°C.
The membrane was then incubated with specific secondary anti-
body Peroxidase AffiniPure Goat Anti-Rabbit/Mouse IgG
(1:10,000 dilution; Jackson). Proteins were visualized by means
of an enhanced chemiluminescence detection system (ECL™,
Amersham, ArlingtonHeights, IL). After acquisition by aGelDoc-
TM image capture system (Kodak), the proteins present on the
nitrocellulose membrane were quantified using ImageJ software.
iPS obtainment and differentiation to neural stem cells
About 5 × 105 PBMCs were cultured for 4 days in 24-well plates in
PBMCs medium (StemPro™-34 + SCF 100 ng/mL, FLT-3 100 ng/
mL, IL-3 20 ng/mL, IL-6 20 ng/mL). Cells were transfected using
viruses provided by CytoTune®-iPS 2.0 Sendai Reprogramming
Kit (Invitrogen). After 24 h, the medium was replaced with fresh
complete PBMCs medium to remove the CytoTune™ 2.0 Sendai
reprogramming vectors. After 2 days, cells were plated on vitro-
nectin-coated culture dishes in complete StemPro™-34 medium
(Invitrogen) and the spent medium was replaced every day for 4
days. After 7 days from transfection, the StemPro™-34 medium
was replaced in Essential 8 Medium (Invitrogen) changing it
every day for 3 weeks. Undifferentiated colonies were manually
picked and plated on vitronectin-coated well (Invitrogen).
Colonies were split using 0.5 mM EDTA for five passages. At
passage 6, the differentiation was started by replacing essential 8
mediumwith PSCneural inductionmedium (neurobasalmedium
supplemented with Neural Induction Supplement, Invitrogen).
After 7 days, iPSCs differentiated into NSCs. NSCs were then
differentiated into Neurons for the following 8 days (Neurobasal
Medium supplemented with B-27, Invitrogen).
Statistical analysis
Data are expressed asmean ± SD.When only two value sets were
compared, the statistical analysis was performed with Student’s
t-test. When three or more value sets were analyzed, one-way
ANOVA was used and Bonferroni’s post-test was applied. The
Prism 5 software (GraphPad Software Inc., La Jolla, CA) was
used assuming a P value less than 0.05 as the limit of significance.
Results
LncRNAs expression levels change during neural
differentiation of primary NSCs in vitro
In this work, we decided to investigate the expression of a panel of
11 lncRNAs in neural differentiation. These lncRNAs have been
investigated in murine knock out models and have been shown to
be necessary for life and correct development [16]. The aimwas to
investigate the role that they play in neural development, analyz-
ing their expression levels in NSCs and during the differentiation
process. NSCs are neural precursor cells derived from the sub-
ventricular zone (SVZ), a neurogenic niche present in the adult
mouse brain [32,33]. When cultured in standard medium, in
absence of serum and in presence of growth factors (bFGF 20
ng/ml and EGF 20 ng/ml) [28], NSCs form spheroid-shaped
floating cell aggregates named neurospheres. Neurospheres can
be dissociated and induced to differentiate when plated in differ-
entiation media, following a specific time schedule and in the
presence of an adhesion substrate (Matrigel™) [28,29]. To investi-
gate the expression of the 11 lncRNAs during the differentiation
process samples were collected at day 1, 3 and 8 (Supplementary
Figure 1(a)). Our results report that lincENC1, FABL, lincp21,
HAUNT and PERIL were down-regulated during neural differ-
entiation (Figure 1(a) and Supplementary Figure 1(b)), whilst
lincBRN1a, lincBRN1b, TUG1 and FENDRR showed the opposite
behaviour (Figure 1(b) and Supplementary figure 1(b)). HOTTIP
is not significantly deregulated suggesting that it probably does
not have a strong implication in this process, and Mdgt was not
expressed, in line with previous literature which demonstrated
that this lncRNA is not particularly expressed in the brain and in
ES-NSCs (Figure 1(c) and Supplementary figure 1(b)) [16].
GAPDH was used as an endogenous control.
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LincBRN1a and lincBRN1b have a role in stemness’
maintenance
We decided to focus on the role of two lncRNAs, lincBRN1a and
lincBRN1b, in the differentiation of NSCs, analyzing more in
depth their possible targets. Indeed, the role of lincBRN1a and
lincBRN1b in brain development has already been characterized
in murine knock out models, providing a solid scientific basis for
our subsequent analyses [18]. Our aim was to characterize this
process at a moremicroscopic level, investigating what happens at
a cellular level. To do so, we silenced lincBRN1a and lincBRN1b
and evaluated the effect that they play in NSCs and during the
differentiation process. We thus performed neurospheres
formation assays andNSCs differentiation assays both in standard
conditions (mock) and in the presence of siRNAs for the two
lncRNAs (siBRN1a.1, siBRN1a.2; siBRN1b.1, siBRN1b.2). The
efficiency of the silencing was evaluated by means of Real Time-
PCR (Supplementary figure 2(a)). In NSCs, all the four siRNAs
were efficient in silencing the two investigated lncRNAs
(Supplementary Figure 2) and were used for further experiments
(Real Time-PCR and immunofluorescence analysis). NSCs main-
tained in standard stem cell medium and silenced for these
lncRNAs were still able to aggregate and form neurospheres
(Figure 2(a)) which, after 7 days of lincBRN1a and lincBRN1b’s
silencing, resulted significantly increased in number, for all silen-
cing except for the one involving siBRN1a.1 (Figure 2(b)).
Figure 1. Expression analysis of a pool of lncRNAs during mice NSCs differentiation.
(a). LincENC1, FABL, lincp21, HAUNT and PERIL expression levels were analyzed in neurospheres (NSCs) and at different time points during the differentiation process (d1, d3,
d8 DIFF). These lncRNAs decrease during the differentiation process. Quantification was performed by real time-PCR using GAPDH as housekeeping gene. Results are
expressed as mean of three different experiments ± SD (*p < 0.05, **p < 0.01, ***p < 0.001 vs NSCs; °p < 0.05, °°°p < 0.001 vs d1).(b). LincBRN1A, lincBRN1B, TUG1 and
FENDRR expression levels were analyzed in neurospheres (NSCs) and at different time points during the differentiation process (d1, d3, d8 DIFF). These lncRNAs increase
during the differentiation process. Quantification was performed by Real Time-PCR using GAPDH as housekeeping gene. Results are expressed as the mean of three different
experiments ± SD (*p < 0.05, ***p < 0.001 vs NSCs; °°°p < 0.001 vs d1; #p < 0.05 vs d3).(c). Hottip and Mdgt expression levels were analyzed in neurospheres (NSCs) and at
different time points during the differentiation process (d1, d3, d8 DIFF). These lncRNAs stay stable during the differentiation process. Quantification was performed by real
time-PCR using GAPDH as housekeeping gene. Results are expressed as the mean of three different experiments ± SD.
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Similarly, the neurospheres’ dimension resulted significantly
increased when silenced with siBRN1a.2 and siBRN1b.1 (Figure
2(b) and Supplementary Figure 2(b)).
Stemness markers SOX2, Nanog and OCT4 were all reduced
in conditions silencing lincBRN1b, and SOX2 and OCT4 were
also reduced when siBRN1a was silenced (Figure 2(c)).
Immunofluorescence analysis showed that when either
lincBRN1a or lincBRN1b were silenced there was a reduction
in the expression of neural precursor marker Nestin, and an
increase in neuronal markers MAP2 and βTubIII. Astrocyte
marker GFAP remained unchanged (Figure 2(d)).
NSCs were then induced to differentiate both in standard
conditions (mock) and in the presence of siRNAs for the
lncRNAs (siBRN1a.1, siBRN1a.2, siBRN1b.1 and siBRN1b.2)
and, under silencing conditions, NSCs were still able to differ-
entiate (Supplementary Figure 3(a)). The silencing was efficient
for all four siRNAs, with an efficiency of 90% for siBRN1a.1 and
siBRN1a.2 and an efficiency of 75% for siBRN1b.1 and
siBRN1b.2 (Supplementary Figure 3(b)). Both stemness (SOX2,
Nanog and OCT4) and neural precursors (Nestin) markers
resulted reduced after 8 days of differentiation in the presence
of the silencing (Figure 3(a)). By immunofluorescence analysis
we investigated the expression of classical neural differentiation
markers and we found that, when the expression of lincBRN1a
and lincBRN1b was inhibited, this resulted in an increase in
neuronal markers (MAP2 and βTubIII), an increase in the
astrocyte marker GFAP and a decrease in the expression of
neural precursor marker Nestin (Figure 3(b)). Together, these
Figure 2. Silencing of lincBRN1a and lincBRN1b in NSCs.
(a). In vivo direct light images (EVOS FL microscope, Euroclone) of neurospheres maintained in stem cells medium for 8 days in standard floating conditions (MOCK)
or in the presence of silencing agents for lincBRN1a (siBRN1a.1 and siBRN1a.2) and lincBRN1b (siBRN1b.1 and siBRN1b.2). Scale bar 400 μm. Images are representative
of what has been observed in three different experiments.(b). The histograms report the neurospheres’ number and dimensions, respectively, in standard conditions
(MOCK), and in the presence of silencing agents for lincBRN1a (siBRN1a.1 and siBRN1a.2) and lincBRN1b (siBRN1b.1 and siBRN1b.2). The number of neurospheres was
calculated as the number of spheroids formed by 104 seeded NSCs in the different conditions. The dimension was reported as volume measured by means of ImageJ
software culture picture analysis. Pictures are representative of three different experiments. Quantifications were repeated in triplicate for each experiment and data
is reported as mean ± SD (**p < 0.01, ***p < 0.001 vs MOCK; °°p < 0.01, °°°p < 0.001 vs siBRN1a.1; $p < 0.05, $ p < 0.001 vs siBRN1a.2; ###p < 0.001 vs siBRN1b.1).(c).
The histograms report the mRNA expression levels of SOX2, Nanog and OCT4 in standard conditions (MOCK), and in the presence of silencing agents for lincBRN1a
(siBRN1a.1 and siBRN1a.2) and lincBRN1b (siBRN1b.1 and siBRN1b.2). Quantification was performed using GAPDH as housekeeping gene. Results are expressed as
mean ± SD of three independent experiments (*p < 0.05, ***p < 0.001 vs MOCK; $ p < 0.05, [Math Processing Error] p < 0.01 vs siBRN1a.1; °°°p < 0.001 vs siBRN1a.2).
(d). Confocal images of neurospheres marked with Nestin (red), Map2 (green), βTubIII (red) and GFAP (green) in standard conditions (MOCK), and in the presence of
silencing agents for lincBRN1a (siBRN1a.2) and lincBRN1b (siBRN1b.1). DAPI (blue) was used as counter-staining. Scale bar 50 μm. The graph reports the quantification
of fluorescence intensity made by ImageJ picture analysis software. Pictures are representative of three different experiments performed with siBRN1a.2 and
siBRN1b.1 but similar results were obtained with siBRN1a.1 and siBRN1b.2. Quantifications was repeated in triplicate for each experiment (3 fields/experiment) and
data have been reported as mean ± SD (*p < 0.05; *** p < 0.001 vs MOCK).
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results show that the absence of lincBRN1a and lincBRN1b leads
to an increase in the differentiation ability of NSCs, suggesting
their implication in the maintenance of cellular stemness.
The RBP HuR binds to lncRNAs both in neurospheres and
during neuronal differentiation
LncRNAs often exert their roles in concomitance with partner
proteins that guide their ability to activate or repress gene
expression or to post-transcriptionally regulate other RNAs.
The RBP HuR has recently been correlated to stem cells’ plur-
ipotency in muscle differentiation in relation to the lncRNA
MD1 [24], and to this end, we decided to investigate whether
HuR possibly interacts with the panel of lncRNAs that were
found deregulated during NSC differentiation. HuR’s expression
was investigated by immunofluorescence analysis in the subven-
tricular zone (SVZ) of adult mouse brain, fromwhichNSCs were
isolated. The protein results notably expressed in this brain area
(Supplementary Figure 4(a)), and the immunofluorescence ana-
lysis shows that HuR in this region co-localizes mostly with
Nestin and Doublecortin (DCX), markers of neural precursor
cells, but not with Glial Fibrillary Acidic Protein (GFAP), an
astrocyte marker (Supplementary Figure 4(b)). Neurospheres
also show a strong expression of HuR (Figure 4(a)). NSCs were
then differentiated for 8 days and the expression of microtubule
associated protein (MAP2), a neuronal-specific marker, was
evaluated by immunofluorescence in order to verify neuronal
differentiation (Figure 4(b)). HuR’s expression is significantly
increased throughout the in vitro differentiation process, as
shown both with immunofluorescence and western blot analysis
(Figure 4(b,c)) [28,29].
A bioinformatics analysis was performed in order to
investigate the presence of potential HuR-binding sites in
the lncRNAs sequences and three different in silico
approaches were used (Figure 5(a)). Firstly, the RNA-
Protein Interaction Prediction (RPISeq, http://pridb.gdcb.ias
Figure 3. Silencing of lincBRN1a and lincBRN1b in differentiated NSCs.
(a). The histograms report the mRNA expression levels of Nestin, SOX2, Nanog and OCT4 in standard conditions (MOCK), and in the presence of silencing agents for
lincBRN1a (siBRN1a.1 and siBRN1a.2) and lincBRN1b (siBRN1b.1 and siBRN1b.2). Quantification was performed using GAPDH as housekeeping gene. Results are
expressed as mean ± SD of three independent experiments (***p < 0.001 vs MOCK).(b). Confocal images of differentiated NSCs marked with Nestin (red), Map2
(green), βTubIII (red) and GFAP (green) in standard control conditions (MOCK), and in the presence of silencing agents for lincBRN1a (siBRN1a.2) and lincBRN1b
(siBRN1b.1). DAPI (blue) was used as counter-staining. Scale bar 50 μm. The graph reports the quantification of fluorescence intensity made by ImageJ picture
analysis software. Pictures are representative of three different experiments. Quantifications were repeated in triplicate for each experiment and data have been
reported as mean ± SD (** p < 0.01, *** p < 0.001 vs MOCK; # p < 0.05 vs siBRN1a.2). Pictures are representative of three different experiments performed with
siBRN1a.2 and siBRN1b.1 but similar results were obtained with siBRN1a.1 and siBRN1b.2.
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tate.edu/RPISeq/) was used to test the possible interaction
between the lncRNAs and HuR. A score >0.5 was considered
‘positive’ (following the guidelines provided by the website)
for a possible interaction (YES) and all the lncRNAs showed
a possible interaction with the RBP. Secondly, the RBPmap
database (http://rbpmap.technion.ac.il/1541972084/results.
html) was used to identify the number of potential interac-
tion sites obtained with a ‘high stringency’ filter. All of the
lncRNAs analyzed have at least 1 potential binding site for
HuR, except for lincBRN1a. However, when a low stringency
was applied, 2 potential binding sites for HuR were found
also in lincBRN1a. Lastly, the lncRNAs sequences were
aligned to the RNAbp database (RBPDB, http://rbpdb.ccbr.
utoronto.ca/index.php) [34]. This database allows for identi-
fication of all potential RNAbp-binding sites, using a default
threshold score of 0.8 (indicated by the website as the opti-
mal cut-off in order to have a ‘confident’ score of the
lncRNAs-protein interaction). All the RNAs analyzed
showed confident HuR-binding sites, ranging from 3 to 69,
which presented to be analogous to the U-rich sequences
bound by HuR. This last database only allows for compar-
ison with the human HuR, which is however conserved
between species. Together, the three approaches demon-
strated a real potential interaction between the lncRNAs
and HuR.
We then decided to validate in vitro these in silico obser-
vations, and we tested HuR’s binding to the full investigated
panel of lncRNAs in neurospheres condition and after
differentiation (day 8) by RNA-immunoprecipitation-assay
(RIP) (Figure 5(b)). HuR binds to lincENC1, FABL lincp21,
HAUNT, and PERIL when in NSCs state; instead, lincBRN1a,
lincBRN1b, HOTTIP, TUG1 and FENDRR were mostly found
bound to HuR after differentiation. The results seem to indi-
cate that HuR binds more copy numbers of the investigated
lncRNAs at the time-point when these are more expressed,
suggesting a possible sponging mechanism of action for the
RNAbp during the differentiation process.
HuR’s activity is involved in neurospheres formation and
maintenance of stemness
In order to evaluate HuR’s role in neurospheres formation and
NSCs differentiation, we tested the effects of its inhibition both by
molecular means, with siRNAmolecules, and by pharmacological
means, with dihydrotanshinone (DT 1µM), an RNA-HuR inter-
action interfering agent [30,35]. NSCs were maintained in stem
cellmedium for 8 days in either standard conditions (mock), in the
presence of siHuRor in the presence ofDT, to evaluate their ability
to form neurospheres (Figure 6(a), Supplementary Figure 5(a)).
The siRNA molecule efficiently inhibited HuR’s expression by
85% (Supplementary Figure 5(b)). NSCs formed neurospheres
presenting different morphology when either siHuR or DT was
added to the culturemedium (Supplementary figure 5(a)). Indeed,
the presence of DT leads to the inability of NSCs to form neuro-
spheres, as they remained in a single cell state (Supplementary
Figure 4. HuR’s expression in mouse brain stem cell niches and during mice NSCs differentiation in vitro.
(a). Immunofluorescence analysis of HuR (red) in neurospheres (NSCs) maintained in stem cells medium. DAPI (blue) was used as counter-staining. Scale bar 50 µm.
(b). Immunofluorescence analysis of HuR (red) at different time points during the neural differentiation process in vitro (days 1, 3 and 8). DAPI (blue) was used as
counter-staining. Scale bar 50 µm. The expression ofMAP2 (green) was tested as differentiation quality control and DAPI (blue) was used as counterstaining. Scale bar
50 μm. (c). Western blot analysis of HuR’s expression in neurospheres (NSCs) and during the differentiation period (days 1, 3 and 8). ß-Actin was used as the loading
control. The histogram shows the band intensity quantification, measured by means of ImageJ software picture analysis. Data correspond to the mean ± SD (*** p <
0.001 vs NSCs; #p < 0.01 vs day1).
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Figure 5(c)), and for this reason, no further studies were per-
formed. Even so, the viability assay shows no toxicity in either of
the two conditions (Mock, siHuR or DT) indicating that HuR’s
inhibition does not lead to cell death (Supplementary Figure 5(d)).
HuR’s silencing caused the downregulation of stemness master
genes, such as SOX2, NANOG and OCT4 (Supplementary Figure
5(e)) and the neurospheres formed were decreased both in num-
ber and dimensions (Supplementary Figures 5(f,g)). HuR’s silen-
cing induced the up-regulation of MAP2 and βTubIII (neuronal
markers) together with the down-regulation of Nestin (neural
precursor marker) and GFAP’s (astrocyte marker) expression in
NSCs (Figure 6(a)). This indicates that HuR’s silencing leads to
a differentiation of NSCs, suggesting a role for HuR in the main-
tenance of neurospheres’ stemness.
NSCs were then differentiated following the previously
described 8-day protocol, and the effects of HuR’s inhibition by
pharmacological (DT) and molecular (siHuR) means were evalu-
ated. In all three conditions (mock, siHuR and DT), NSCs were
able to differentiate into neurons (Figure 6(b), Supplementary 6
(a)) and maintained their vitality (Supplementary figure 6(b)).
Immunofluorescence analysis showed that DT treatment and
HuR’s silencing during the differentiationprocedure lead to anup-
regulation of cells positive to both neuronal markers (MAP2 and
βTubIII) and to oligodendrocytes markers (GALC and Olig2).
GFAP (astrocyte marker) positive cells increased only during DT
treatment, whilst Nestin (neural precursor marker) positive cells
remained constant during bothDT treatment andHuR’s silencing
(Figure 6(b)). Together, these results suggest that HuR is necessary
to maintain the cell stemness state, and its silencing or pharmaco-
logical inhibition induces an early reprogramming of NSCs
towards a neuronal precursors commitment.
HuR regulates the stability of lincBRN1a and lincBRN1b
both in neurospheres and during neuronal differentiation
We decided to further investigate the role that HuR has in regulat-
ing the stability of lincBRN1a and lincBRN1b. RIP assay was
performed in neurospheres and after differentiation (day 8) in
the presence or absence of DT (Figure 7(a)). DT treatment
decreased the expression levels of lincBRN1a and lincBRN1b
in NSCs and at the end of the 8-day differentiation process
(Figure 7(a), Supplementary Figure 7). To further investigate the
role of HuR’s binding in regulating the lncRNAs homeostasis, we
performed a reporter assay in which the investigated U-Rich
sequences (see Materials and Methods section for specific
sequences) were cloned into a luciferase reporter plasmid
Figure 5. LncRNAs and HuR interact and this interaction influences lncRNAs’ expression.
(a). In silico identification of HuR Binding Sites. Three different in silico approaches were used: RNA-Protein Interaction Prediction (RPISeq, http://pridb.gdcb.iastate.
edu/RPISeq/) where a score >0.5 was considered ‘positive’ for a possible interaction (YES); RBPmap database (http://rbpmap.technion.ac.il/1541972084/results.html)
which reports a prediction of the possible interaction sites (obtained with a ‘high stringency’ filter); RNAbp database (RBPDB, http://rbpdb.ccbr.utoronto.ca/index.
php) which identifies the potential RNAbp binding sites (default threshold score of 0.8). (b). RNA-immunoprecipitation assay (RIP) for HuR was performed in
neurospheres grown for 8 days (NSCs) and at the end of the 8-day differentiation process (DIFF). Quantification was performed by real time PCR and results are
expressed as ddCt fold enrichment relative to unrelated IgG, used as IP negative control and performed in triplicate. Results are expressed as mean of three different
experiments ± SD (*p < 0.05, ** p< 0.01, ***p < 0.001 vs NSCs).
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mimicking the 3ʹUTR of the luciferase cDNA (Figure 7(b)) [27].
The constructs were tested in both stemness and differentiation
conditions in presence of HuR’s ablation (siHuR). The results
showed that U-Rich elements present in lincBRN1b are necessary
for luciferase activity together with HuR’s expression in stem cells
status. Furthermore, the same elements in lincBRN1b, and to
a modest extent in lincBRN1a, are necessary in the differentiated
status (Figure 7(b)). Actinomycin-D, an inhibitor of transcription
[36], was added both to neurospheres and to differentiated NSCs.
This resulted in a gradual modification of the decay rate of the
investigated lncRNAs (Figure 7(c)). The RNA expression levels
were monitored at 30 min, 1, 3, 6, and 12 h after actinomycin-D
treatment in the presence or absence of HuR’s molecular down-
regulation (siHuR). Actinomycin-D is a transcription inhibitor,
and thus its addition to the cell’s growing medium allows to
investigate the decay rates of the RNAmolecules. HuR’s silencing
resulted in different modulations of the lncRNAs decays relatively
to the cellular differentiation status. LincBRN1a is affected both in
NSCs and during differentiation. Specifically, in the NSCs state,
the half-life decreases from being over 12 h to 6 h 24 min when
HuR is silenced, indicating that HuR has a role in stabilizing this
lncRNA. Similarly, during differentiation, HuR’s silencing
decreases lincBRN1a’s half-life from over 12 h to 2 h 43 min.
HuR’s downregulation increases lincBRN1b’s decay rate in NSCs
state. In this case, the decay rate decreases from over 12 h to 2 h 49
min. Results suggest that HuR’s binding to the different lncRNAs
Figure 6. HuR’s inhibition and silencing in neurospheres and in differentiated NSCs.
(a). Confocal images of neurospheres marked with Nestin (red), Map2 (red), βTubIII (green) and GFAP (green) in the presence (siHuR) or absence (MOCK) of siHuR.
DAPI (blue) was used as counter-staining. Scale bar 20 μm. The graph reports the quantification of fluorescence intensity made by ImageJ picture analysis software.
Pictures are representative of three different experiments. Quantifications were repeated in triplicate for each experiment (three fields/experiment). Data correspond
to the mean ± SD (*p < 0.05, ** p < 0.01, *** p < 0.001 vs MOCK)(b). Immunofluorescence analysis of neural precursor marker Nestin (red) and neuronal markers Gal
C (red), GFAP (red), Olig2 (red), ßTubIII (red) and MAP2 (green) at the end of differentiation process. NSCs were differentiated in standard conditions (MOCK) or in the
presence of either siHuR (siHuR) or DT (DT). DAPI (blue) was used as counter-staining. Scale bar 50 µm. The quantification of the fluorescence intensity was made by
ImageJ picture analysis software. Pictures are representative of three different experiments. Quantifications were repeated in triplicate for each experiment (three
fields/experiment). Data correspond to the mean ± SD (** p < 0.01, *** p< 0.001vs NTC; ## p < 0.01, ### p < 0.001 vs siHuR).
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plays different roles depending on cell status (neurospheres or
differentiated neurons). This may suggest for a time-dependent
role of these lncRNAs during the neuronal differentiation process.
Murine lncRNAs present human homologues and four of
these are deregulated during iPSCs’ differentiation
For the panel of lncRNAs investigated, the presence of human
homologues was evaluated according to NCBI guidelines and
according to Mouse Genome Database (http://www.informatics.
jax.org/marker/MGI:3780541). When no homology was detected,
sequence-based similarity was evaluated using Blast online tool.
Human homologues were found for lincENC1 (Human name:
LINC01157), ELDRR (Human name: ELDRR), lincBRN1a
(Human name: PANTR1), lincp21 (Human name: TP53COR),
HOTTIP (Human name: HOTTIP), TUG1 (Human name:
TUG1) and FENDRR (Human name: FENDRR) (Table 1). For
the ones for which it was possible to obtain a reference sequence
and thus design primers, subsequent analyses were performed.
These were: PANTR1, TUG1, HOTTIP, TP53COR, ELDRR and
FENDRR. To investigate the role for these homologues in human
stem cells, induced pluripotent stem cells (iPSCs) were obtained
from PBMCs of n = 3 healthy subjects and then induced to
differentiate, firstly into NSCs and then into neurons.
Immunofluorescence analysis demonstrated positivity to stemness
markers SSEA4, OCT4, SOX2 and TRA-1–60 (Supplementary
Figures 8(a,b)). RT-PCR analysis shows the presence of the virus
injected SeV, Klf4, c-Myc and KOS, indicating successful repro-
gramming (Supplementary Figure 8(c)). The expression of the
lncRNAs was then evaluated in the pluripotency state (iPSCs)
and during their differentiation to neural precursors (h-NSCs)
and then neurons (h-Neurons) (Figure 8(b)). Whilst HOTTIP,
Figure 7. Investigation of the interaction between HuR and lincBRN1a/lincBRN1b.
(a). RNA immunoprecipitation assay (RIP) for HuR was performed in neurospheres (NSCs) and at the end of the 8-day differentiation process (DIFF). Cells were
analyzed in the presence or absence of dihydrotanshinone (DT 1µM), an RNA-HuR interaction interfering agent. LncRNAs lincBRN1a and lincBRN1b show a strong
affinity for the HuR antibody-coated beads and DT destroys this interaction, indicating a specific interaction between the RNA-binding protein and the lncRNAs.
Quantification was performed by Real time PCR and quantification was expressed with reference to the input. Results are expressed as the mean of three different
experiments ± SD (*** p < 0.001 vs NSCs; °°° p < 0.001 vs DIFF; with n = 3). (b). Luciferase reporter assay performed on NSCs and differentiated cells (DIFF) in the
presence or absence of siHuR. The experiment was performed transfecting reporter plasmids carrying AU-rich regulatory regions of lincBRN1a and lincBRN1b, 3ʹUTR
SOX2 reporter was used as positive control. Results are expressed as the mean of three different experiments ± SD. (c). RNA turnover assay. The lncRNAs expression
levels (lincBRN1a and lincBRN1b) were monitored at 30 min, 1, 3, 6 and 12 h after the administration of Actinomycin D in presence or absence of HuR silencing
(siHuR). Results are expressed as the mean of three different experiments ± SD (*p < 0.05 vs NSCs MOCK; ° p < 0.05 vs DIFF MOCK; with n = 3).
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TP53COR, ELDRR, TUG1 and FENDRR showed no significant
deregulation, PANTR1 was significantly downregulated in
h-NSCs. During neuronal differentiation, HOTTIP, TP53COR,
ELDRR and PANTR1 expression was increased. No significant
deregulation was found for TUG1 and FENDRR. Furthermore,
HuR is present in iPSCs, h-NSCs and h-Neurons, as shown by
immunofluorescence and western blot analysis (Figure 8(a,c)).
Discussion
In recent years, our understanding of the molecular mechanisms
regulating adult NSCs (NSCs) specification, proliferation and
differentiation has increased, with several works focusing their
efforts on the comprehension of these mechanisms [2–4,13,37].
lncRNAs are a class of RNA molecules, and although not much
is known concerning their mechanism of action, they seem to be
necessary for correct cellular functioning. Indeed, the genetic
ablation of certain lncRNAs implies strong cellular and devel-
opmental dysfunctions [38,39]. Aberrant lncRNA expression has
been associated with some of the most devastating neurological
diseases including glioma [40], schizophrenia [41], Alzheimer’s
disease [42], developmental delay [43], and autism [44].
Moreover, analyses performed in some specific cell lineage or
in pathologic CNS conditions, such as schizophrenia, report that
the expression of lncRNAs is dynamically regulated during CNS
development NSCs differentiation [45,46]. Furthermore, the
state of activation in neurons is responsible for their regulation
[41,47]. To dissect the functional and physiologic role of
lncRNAs, loss-of-function and gain-of-function experimental
approaches are required. Following these approaches, it has
been possible to clarify crucial processes in which these mole-
cules are involved, such as XIST, which exerts a fundamental role
in the random inactivation of the X chromosome [48], Air which
is crucial for imprinting control at the Igf2r locus [49], HOTAIR
that controls the expression of the HOXD gene family [50], and
HOTTIP that affects the expression of the HOXA gene family
[17]. It has been shown that specific lncRNAs are necessary for
mouse brain development and NSCs differentiation [16]. Here,
we firstly report the presence of a global deregulation in this
panel of lncRNAs (lincENC1, FABL, lincBRN1a, lincBRN1b,
lincp21, HOTTIP, HAUNT, TUG1, PERIL and FENDRR) dur-
ing NSCs’ differentiation into neural precursors, thus suggesting
a role for them in this process.We then decided to investigate the
role that two lncRNAs, lincBRN1a and lincBRN1b, play at
a cellular level, in order to gain insights into what could be the
molecular pathway in which they are involved. Indeed, their
importance in macroscopic brain development has already
been characterized in murine models, where lincBRN1a and
lincBRN1b have been shown to be expressed in specific layers
of the cerebral cortex, in the hippocampus (lincBRN1a) and in
the habenular nucleus (lincBRN1b) [18]. In mice, lincBRN1a
and lincBRN1b are flanking both sides of the POU-domain gene
family member Pou3f3 (Brn1), a key transcription factor
involved in cortical development [19,51]. LincBRN1b shares
a bidirectional promoter with Pou3f3, whereas lincBRN1a is
located ∼13.2 kb downstream of Pou3f3 in the opposite orienta-
tion [18]. These two lncRNAs have been investigated during
mouse brain development and have been shown to be specifi-
cally and dynamically regulated in the adult brain [18].
Transcriptome analysis of the whole brain at E14.5 in specific
knock out animals revealed that the ablation of the Pantr1 locus
Table 1. Identification of human homologues of murine lncRNAs.
LncRNA Mouse
ID mouse
(RefSeq)
Human homology
(gene name) ID human Additional info (human) Source
LincENC1 NR_1104301.1 LINC01157 ENSEMBL ID: not available
NCBI gene ID: 105379037
RefSeq: not available
Long intergenic nonprotein coding RNA 1157 HGNC
FABL (ELDRR) NR_110421.1 ELDRR ENSEMBL ID:
ENSG00000280890
NCBI gene ID: 102725541
RefSeq: NR_110426
EGFR long noncoding downstream RNA HGNC
LincBRN1b (PANTR2) NR_110495.1 No homology found
LincBRN1a (PANTR1) NR_027826.1 LINC01158 ENSEMBL ID:
ENSG00000233639
NCBI gene ID: 100506421
RefSeq: NR_037833
Long intergenic nonprotein coding RNA 1158 HGNC
Lincp21 (Trp53cor1) NR_036469.2 TP53COR1 ENSEMBL ID: not available
NCBI gene ID: 102800311
RefSeq: not available
Tumor protein p53 pathway corepressor 1 (nonprotein
coding)
HGNC
HOTTIP NR_110441.1 HOTTIP ENSEMBL ID:
ENSG00000243766
NCBI gene ID: 100316868
RefSeq: NR_037843
HOXA distal transcript antisense RNA HGNC
HAUNT (halr1) NR_110440 No homology found
TUG1 NR_002321.2 TUG1 ENSEMBL ID:
ENSG00000253352
NCBI gene ID: 55000
RefSeq: NR_002323.2
Taurine upregulated 1 HGNC
PERIL (PERL/Gm38509) NR_110488.1 No homology found
FENDRR NR_130109.1 FENDRR ENSEMBL ID:
ENSG000002682388
NCBI gene ID: 400550
RefSeq: NR_0033925.1
FOXF1 adjacent non-coding developmental regulatory
RNA
HGNC
Gene homology between human and mouse. Homology was evaluated according to NCBI guidelines and according to Mouse Genome Database (http://www.
informatics.jax.org/marker/MGI:3780541). When no homology was detected, sequence-based similarity was evaluated using Blastn online tool.
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resulted in significant up-regulation of some neuronal progeni-
tor markers such as Nestin, Notch1, Pax3, and Pax6, and sig-
nificant down-regulation of mature neural cell-type markers
including many canonical astrocyte markers such as Gfap,
S100b, Aldh1l1, Fabp7, and Gap43 [18].
Here, we demonstrated that these are also present in NSCs
isolated from the SVZ, and that their expression levels increase
during neuronal differentiation. By silencing means, we demon-
strated that the loss of the two lncRNAs, both in neurospheres
state and during the differentiation process, leads to a strong
induction of the differentiation process, with an increase in neu-
ronal markers and a decrease in stemness markers. This indicates
a potential role for the two lncRNAs in the maintenance of the
stemness process, as they could be crucial regulators of genes
involved in neuronal differentiation. Analyses performed in the
adult brain of knock out mice suggested to Goff and co-workers
that these two lncRNAs have a strikingly different expression
pattern in the adult brain [18]. More in-depth analysis, with
tools such as RNAseq and gene expression modulation experi-
ments, is however needed to identify the specific targets of these
lncRNAs. Even so, our second aim was to find a potential inter-
actor through which these lncRNAs could exert their functions.
HuR is a well-characterized RBP promoting cellular proliferation
and involved in mRNA splicing and stabilization [21–23]. This
protein is present within the cell in the nuclear and cytoplasmic
sub-compartments and cooperates with splicing and translation
regulatory factors [52–54]. Moreover, it was recently demon-
strated that HuR is involved in SOX2 mRNA homeostasis and
stemness maintenance [27]. Here, we report HuR’s ability to bind
the lncRNAs under analysis and to modulate their half-lives.
Moreover, we demonstrate that when HuR’s activity is inhibited
during NSCs’ differentiation there is an increase in stemness
potential. Indeed, HuR’s silencing and pharmacological inactiva-
tion also lead to an increase in neuronal markers and a decrease in
stemness markers, with similar results as to the ones obtained
when lincBRN1a and lincBRN1b were silenced. This indicates
a concordant and possibly synergic action for the molecules in
the differentiation process of NSCs, probably due to their physical
interaction. Moreover, we show that this binding is crucial for
their turnover homeostasis. It has been demonstrated that HuR
binds to linc-MD1 and H19 lncRNA. The level of linc-MD1
expression positively correlated with HuR protein abundance, as
does the level of miR-675, a microRNA embedded in H19
lncRNA [24,55,56]. These authors showed that HuR regulates
Figure 8. Expression of HuR and human homologues of lncRNAs during neuronal differentiation of h-iPSCs.
(a). Immunofluorescence analysis of HuR (red) and MAP2 (green) in h-NSCs and h-Neurons. DAPI (blue) was used as counter-staining. Scale bar 20 µm. (b). Expression
analysis of human homologues of lncRNAs PANTR1, HOTTIP, ELDRR TP53COR, TUG1 and FENDRR in iPSCs (h-iPSCs), NSCs (h-NSCs) and neurons (h-Neurons).
Quantification was performed by means of Real Time-PCR using GAPDH as housekeeping gene. Results are reported as mean ± SD (***p < 0.001; vs h-iPSCs, ###p <
0.001 vs h-NSCs n = 3).(c). Western blot analysis of HuR’s expression in h-iPSCs, h-NSCs and h-Neurons (NSCs). ß-Actin was used as the loading control. The histogram
shows the band intensity quantification, measured by means of ImageJ software picture analysis.
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the fate of linc-MD1 and H19 lncRNA/miR-675, as the cellular
depletion of HuR enhances the processing of linc-MD1 into miR-
133b and of H19 lncRNA intomiR-675. HuR’s role inmyogenesis
and embryogenesis shows its interaction with lncRNAs, regulat-
ing their processing to microRNAs and fine-tuning the differen-
tiation program acting on themicroRNA developmental reservoir
[13]. In this paper, we firstly report HuR’s ability to bind U-rich
regions of lincBRN1a and lincBRN1b. Indeed, HuR’s inhibition
leads to an increase in their decay rates, thus suggesting a role for
the protein in lncRNAs’ stabilization and regulation of the half-
life. The increase in lncRNAs turnover does not necessarily imply
a lack of function as themodification of lncRNAs stability can also
influence the time and the localization of their activity. Again,
more experiments with big data set analysis of regulatory path-
ways, such as microarrays, high-through put proteomic and next-
generation sequencing will be necessary to determine the precise
targets of these interactions.
In conclusion, our data on HuR’s inhibition in neurospheres
and in NSCs’ differentiation encourage us to speculate that the
interaction between HuR and specific lncRNAs involved in
neural differentiation can be a proper target for a fine-tune
modulation of stemness and differentiation. This mechanism
could potentially also be translated to human lineages, where
homologues are present for six of the lncRNAs under investiga-
tion (lincBRN1a/PANTR1, TUG1, FENDRR, HOTTIP, FABL/
ELDRR and lincp21/TP53COR), one of which (PANTR1) man-
ifests a significant deregulation when differentiated from human
iPSCs into NSCs. Moreover, the expression levels of HOTTIP,
TP53COR, ELDRR, and PANTR1 were increased during neu-
ronal differentiation of h-NSCs . This opens a new path of
research that may help a better understanding of new post-
transcriptional mechanisms that regulate the expression of
RNAs involved in NSC differentiation. A deregulation of these
molecules could be present in neurodevelopmental and neuro-
degenerative diseases, allowing for the investigation of new dis-
ease-pathways. Moreover, the interaction between HuR and
certain lncRNAs may represent also a new potential pharmaco-
logical target allowing cell precursor’s conversion to neurons for
their application in regenerative medicine. Together, these
results support and evidence the importance of certain
lncRNAs in neural development, and they show the importance
of HuR in regulating their stability and thus functionality.
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